DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Abergel A, Hezode C, Asselah T. et al.
High efficacy and safety of the combination HCV regimen elbasvir and grazoprevir for 8 weeks in treatment-naive non-severe fibrosis HCVGT1b-infected patients: Final results of the STREAGER study.
Journal of hepatology 2019;
70: E207-E207
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.